kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Promising direction for the treatment

Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

SKU: 77048767325 · From vanxuanam.com